Fane Mensah

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Fane Mensah, PhD., studied immunology, specifically B cells and immunometabolism, in the division of Medicine at University College London, a public research university in London, England.[1] He serves as the Head of Community at the Computer-Aided Biology Community and Scientific Community Manager at Synthace Limited, both of London, UK.[2] He is the managing director of the Science Entrepreneur Club, a non-profit organization whose goal is to foster innovation and talent in the life science ecosystem.[3]

Education[edit | edit source]

  • 2011, BSc degree in Biology and medical research, Rotterdam University of Applied Sciences[4]
  • 2013, MSc degree in Infection and Immunity, Erasmus University Rotterdam[4]
  • 2019, PhD in Immunology, University College London[4][5]

Doctorate thesis[edit | edit source]

  • 2019, Title: Investigations of B cell phenotype and metabolic function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; awarded by UCL (University College London).[5] - (Abstract)

Awards[edit | edit source]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Fane Mensah". ResearchGate. February 6, 2019.
  2. "Fane Mensah, MSc, PhD". LinkedIn. Retrieved May 11, 2020.
  3. "The Team". February 6, 2019.
  4. "Fane Mensah". LinkedIn. February 6, 2019.
  5. 5.05.1 Mensah, Fane Kojo Fosu (2019). "Investigations of B cell phenotype and metabolic function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". UCL Discovery. Retrieved May 11, 2020.
  6. "2016 Ramsay Award Program Results - Solve ME/CFS Initiative". Solve ME/CFS Initiative. Retrieved October 22, 2018.
  7. "Metabolic Analysis of B-Cell Maturation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Solve ME/CFS Initiative. December 7, 2016. Retrieved February 18, 2020.
  8. Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749
  9. Mensah, Fane; Bansal, Amolak; Ford, Brian; Cambridge, Geraldine (2017), "Chronic fatigue syndrome and the immune system: Where are we now?", Neurophysiologie Clinique, 47 (2): 131-138, doi:10.1016/j.neucli.2017.02.002
  10. Mensah, Fane F.K.; Armstrong, Christopher W.; Reddy, Venkat; Bansal, Amolak S.; Berkovitz, Saul; Leandro, Maria J.; Cambridge, Geraldine (2018). "CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Immunology. 9. doi:10.3389/fimmu.2018.02421. ISSN 1664-3224.
  11. "UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". Invest in ME Research. Retrieved October 22, 2018.
  12. "Scientists and Dr Tuller brief Australia's Chief Medical Officer". ME Australia. April 22, 2018. Retrieved October 2, 2018.

B cell B lymphocyte, or a type of white blood cell, which is involved in the immune response by secreting antibodies to ward off infections. In mammals, they are mostly matured in the bone marrow.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.